Basic information Safety Supplier Related

SC-1

Basic information Safety Supplier Related

SC-1 Basic information

Product Name:
SC-1
Synonyms:
  • SC-1
  • N-[4-Chloro-3-(trifluoromethyl)phenyl]-N′-[4-(4-cyanophenoxy)phenyl]-urea
  • Urea, N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-[4-(4-cyanophenoxy)phenyl]-
  • SC-1 >=98% (HPLC)
  • 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea
  • STAT,cyclin-D1,Inhibitor,inhibit,kinase,Apoptosis,1(4Chloro3(trifluoromethyl)phenyl)3(4(4cyanophenoxy)phenyl)urea,p-STAT3,orally,anticancer,SHP-1,1 (4 Chloro 3 (trifluoromethyl)phenyl) 3 (4 (4 cyanophenoxy)phenyl)urea,survivin
  • Compound SC-1
  • 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea, 10 mM in DMSO
CAS:
1313019-65-6
MF:
C21H13ClF3N3O2
MW:
431.8
EINECS:
806-020-3
Mol File:
1313019-65-6.mol
More
Less

SC-1 Chemical Properties

storage temp. 
2-8°C
solubility 
DMSO: soluble15mg/mL, clear
form 
powder
color 
white to beige
Water Solubility 
Water: Insoluble
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36
Safety Statements 
26
WGK Germany 
3
More
Less

SC-1 Usage And Synthesis

Uses

STAT3-IN-7 is a Sorafenib analogue and potently inhibits the phosphorylation of STAT3. STAT3-IN-7 induces cell apoptosis through SHP-1 dependent STAT3 inactivation. STAT3-IN-7 does not inhibit kinase activity and has anticancer effects[1].

Biological Activity

SC-1 is a derivative of the multiple tyrosine kinase inhibitor sorafenib with no kinase-inhibition activity. SC-1 blocks STAT3 phosphorylation and activation with similar potency to sorafenib, and induces apoptosis in hepatocellular carcinoma cell lines.

in vivo

STAT3-IN-7 (10 mg/kg; oral gavage; daily; for 28 days; female NCr athymic nude mice) treatment shows efficacious antitumor activity and p-STAT3 downregulation in MDA-MB-468 xenograft tumors[1].

Animal Model:Female NCr athymic nude mice (4-6 weeks of age) injected with breast cancer cells [1]
Dosage:10 mg/kg
Administration:Oral gavage; daily; for 28 days
Result:Showed efficacious antitumor activity and p-STAT3 downregulation in MDA-MB-468 xenograft tumors.

IC 50

p-STAT3

References

[1] Chun-Yu Liu, et al. Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells. Breast Cancer Res. 2013;15(4):R63. DOI:10.1186/bcr3457

SC-1Supplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Email
2853530910@QQ.com
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Email
Sales@ATKchemical.com